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Introduction: We have previously published the outcome of a
community-based lung cancer screening program. We now report on
the 5-year follow-up of this study and include both patients with and
without airflow obstruction.
Materials and Methods: One thousand two hundred fifty-six pa-
tients completed questionnaires in the office of their primary care
physicians, and 430 of this group were assessed to be at high risk for
lung cancer. These patients then underwent spirometry, and 88 of
126 patients with airflow obstruction consented to lung cancer
screening test.
Testing Methods: Complete screening testing included spirometry,
two-view chest radiograph, chest CT scan, and sputum cytology
examinations.
Results: Eight lung cancers were found in the high-risk group with
airflow obstruction. No more cancers were found in the tested group
in the 5 years since the earlier report. Ten cancers were found in the
304 patients with normal airflow, not previously reported. In all, 18
lung cancers were found in 430 patients deemed at risk by a simple
one-page questionnaire (4.2%).
Conclusions: A questionnaire, self-administered in a primary care
office setting, helps identify patients at high risk of lung cancer. If
upcoming results of randomized controlled trials show a benefit of
lung screening, this tool could be of help to select patients for
screening.
Key Words: Lung cancer, Airflow obstruction, Spirometry, CT
scanning, Sputum cytology, Questionnaire.
(J Thorac Oncol. 2009;4: 1347–1351)
Lung cancer is the most common fatal malignancy in theUnited States in both men and women and is occurring at
an alarming rate around the world.1 There is no consensus
from the oncology, radiology, or pulmonary communities
regarding the best approach to diagnosing lung cancer at an
early stage.2 Several reports have been published showing
that lung cancer can be identified and treated at an early
stage3; however, improvement in mortality rates has not been
confirmed.4
This project was designed to identify individuals at
high risk for lung cancer in a family practice clinical setting
and to detect lung cancer in these high-risk individuals.
Previously, we reported our 1-year experience of lung cancer
detection in patients with airflow obstruction in a primary
care outpatient practice.5 This study summarizes the 5-year
follow-up of these individuals, and also the other high-risk
subjects from the same cohort both with and without airflow
obstruction.
MATERIALS AND METHODS
Study Design
Patients visiting their primary care physicians for rou-
tine healthcare concerns were assessed for lung cancer risk by
a short questionnaire completed during that visit. Criteria for
high risk for lung cancer was age 50 years, and one of the
following: (1) current or ex-smoker, 30-pack years; (2)
occupational exposure to asbestos or mining dusts; or(3)
family history for lung, esophageal, or laryngeal cancer.
Patients at high risk for lung cancer underwent spirometry,
and those showing airflow obstruction were offered lung
cancer detection studies consisting of chest radiograph, spu-
tum cytology tests, and chest CT scan. Previously, we pub-
lished the details of this study and found lung cancer in six of
88 high-risk patients.
This follow-up phase of the lung cancer detection
project was designed to restudy the group of 88 high-risk
*Pulmonary Medicine, St Mary’s Hospital, Grand Junction, Colorado; †Sac-
comanno Research Institute, Grand Junction, Colorado; ‡Primary Care
Partners, Grand Junction, Colorado and the Department of Family Prac-
tice, St Mary’s Hospital, Grand Junction, Colorado; §University of
Colorado Health Sciences Center, Denver, Colorado; and Rush Univer-
sity, Chicago, Illinois.
Disclosure: The authors received grant money from FAMRI (Flight Atten-
dants Medical Research Institute) to help with expenses; Dr. Coons was
employed by the Saccomanno Research Institute as a Senior Scientist,
during which time she participated in the research described in this study.
She has also received funds to do other lung cancer related research.
Address for correspondence: Thomas L. Petty, MD, Department of Medicine,
899 Logan Street, Suite 103, Denver, Colorado 80203. E-mail: tlpdoc@
aol.com
Copyright © 2009 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/09/0411-1347
Journal of Thoracic Oncology • Volume 4, Number 11, November 2009 1347
patients with airflow obstruction with spirometry, sputum
cytology tests, and chest CT scan at years 3 and 5. In
addition, we collected available information on the remaining
38 high-risk patients with airflow obstruction and 304 high-
risk patients without airflow obstruction, who were part of the
initial cohort but not consented or studied.
Patient Population
Patients were enrolled from a busy 20-physician family
practice group, Primary Care Partners in Grand Junction,
Colorado. Grand Junction is a small urban community of
50,000 population with a drawing area of 250,000 persons.
Of the1256 questionnaires completed in one calendar
year, January 1, 2001 to December 31, 2001 (Fig. 1), 430 of
these patients were classified as high risk for lung cancer
(Fig. 2). These 430 patients were tested for airflow obstruc-
tion with spirometry, and patients with airflow obstruction
were invited to participate in this project. One hundred
twenty-six patients showed spirometric abnormalities of
which 88 consented and were screened for lung cancer
according to the criteria published previously (Group A).
Thirty-eight additional high-risk patients who were not
screened (Group B) and 304 patients at high risk for cancer
by questionnaire, but with normal spirometry and not
screened (Group C), were concurrently monitored periodi-
cally through hospital and outpatient medical records, hospi-
tal and state tumor registries, and the U.S. Social Security
Death Index. This prospective study was approved by the St.
Mary’s Hospital Institutional Review Board, Grand Junction,
Colorado.
Testing Methods
Spirometry was performed by trained nurses in the
Primary Care Partners offices on the same day of the office
visit. American Thoracic Society standards were followed
and airflow obstruction was diagnosed in patients with forced
expiratory volume in 1 second70% of predicted and forced
expiratory volume in 1 second/forced vital capacity ratio
70%. Posterior, anterior, and lateral chest radiographs were
performed in standard fashion and over-read by two physi-
cians in the initial phase; however, chest radiographs were
not done in the follow-up phase. Sputum cytology examina-
tions consisted of induced and spontaneous cough specimens
prepared and analyzed using the Saccomanno technique.6 All
sputa were interpreted by qualified sputum cytopathologists.
Chest CT scans were performed on individuals using a
helical CT scanner (GE Lightspeed QXI: GE Healthcare
Technologies, Waukesha, WI), taking noncontrast 5.0 mm
(initial phase used 7.5-mm slices) sequential images. These
were independently overread by a second radiologist and a
FIGURE 1. Grand Junction Questionnaire.
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pulmonologist, who did not know the results of the initial
readings. Patients with suspicious sputum cytology or non-
calcified nodules on CT scan were either monitored by their
family physician with follow-up studies or referred to a
pulmonologist for evaluation.
RESULTS
The study patient population was divided into three
groups for data analysis, as noted below.
Group A
Eighty-eight patients showing high risk for lung cancer
by questionnaire, airflow obstruction by spirometry, and stud-
ied by sputum cytology and radiographic studies. Six (6.8%)
of the individuals were diagnosed with lung cancer in the
initial study (Table 1). Three patients survived for 5 years,
two died of noncancer causes (heart disease, chronic obstruc-
tive pulmonary disease), and one died of metastatic lung
cancer at 9 months.
No additional cancers have been diagnosed in this
group during the subsequent 5 years of surveillance. Eight
patients died of nonmalignant disease and two patients have
been lost to follow-up (Table 2).
Group B
This group consisted of 38 patients showing high risk
for lung cancer by questionnaire and abnormal spirometry,
but not studied because of consenting problems or refusal.
Review of available medical records showed that two patients
(5.2%) were subsequently diagnosed with lung cancer (Table
3). One patient has survived 5 years and eight individuals
have died of nonmalignant causes. No follow-up data could
be obtained on 10 individuals.
Group C
Three hundred four patients showing high risk for lung
cancer by questionnaire, but tested normal by spirometry and,
hence, were not studied. Individuals in this group were
monitored only through medical chart reviews and cancer
registries.
Ten lung cancers (3.3%) have been diagnosed in this
group during the follow-up (Tables 4 and 5). No follow-up
information could be found on 40 of these patients (13%). Of
the 264 individuals with some follow-up data available, seven
died of noncancer issues and 61 nonlung-cancer diagnoses
were found, e.g., breast, prostate, skin. Three of the 10 lung
FIGURE 2. Patient population for early lung can-
cer detection study.
TABLE 1. Group A: Outcome of Six Patients Screened for Lung Cancer
Patient Age (yr) Sex
Smoking Pack
Year Cell Type Stage Treatment
Survival Status
After Diagnosis
1 79 F 45 Adenocarcinoma IIIA R Alive 5 yr
2 70 F 46 Adenocarcinoma IA S Alive 5 yr
3 62 M 76 Squamous cell IA S Alive 5 yr
4 62 M 50 Squamous cell/adenocarcinoma 3 CAs S/R Died 19 mo—heart disease
5 84 M 12 Adenocarcinoma IIIA R Died 7 mo—COPD
6 79 F 40 Adenocarcinoma IA R Died 9 mo—CA metastatic lung
R, radiation therapy; S, surgery.
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cancers diagnosed were small cell, and of the remaining
seven non-small cell cancers, five were at advanced stage.
DISCUSSION
Lung cancer can be diagnosed at a relatively high rate
in an outpatient primary care medical practice, as demon-
strated by this prospective study 18 cancers were found in
430 patients (4.1%) selected by a simple one-page question-
naire. Lung cancers detected in six of 88 high-risk patients
with airflow obstruction showed three to be stage 1 disease,
and three of the six survived5 years, both the findings were
better than national statistics.1 Five of the seven non-small
cell cancers found in the unscreened group (C) were ad-
vanced stage III or IV, whereas three of the six in the
screened group (A) were advanced disease, suggesting that
attempts at early detection may be of benefit, although the
total numbers are small. Interestingly, three small-cell can-
cers were subsequently diagnosed in the unscreened group
(C), whereas no small-cell cancers were found in groups A or
B. Of the entire 18 cancer patients found in groups A, B, and
C, five are still alive living 5 years after diagnosis and four
more are alive, 1 to 4 years later. Thus, the survival will be
between 24 and 50%.
Lung cancer was found in a higher percentage of
patients having airflow obstruction (6.8%) compared with
those with no airflow obstruction (3.1%), which is consistent
with previous observations.7–10 Our findings may be skewed,
because a portion of the airflow obstruction patients (group
B) and group C patients did not undergo formal testing. This
suggests that lead-time bias might contribute to these find-
ings, although this is less likely given the 5 years of follow-
up. Follow-up information in groups B and C was incomplete
as these individuals were not consented for the project and,
hence, not a formal part of the study.
Currently, there is no consensus for defining an indi-
vidual as high risk for lung cancer, as evidenced by the
differing criteria used by various authors of early lung cancer
detection studies. However, we do know that lung cancer
occurs more frequently in older individuals, those with air-
flow obstruction and with extensive smoking history, factors
we incorporated into our questionnaire. The self-adminis-
tered, one-page questionnaire used in this project could be
TABLE 2. Group A: Outcome of 88 High-Risk Patients
Screened for Lung Cancer
No. of
Patients Monitoring Status Survival
6 (6.8%) Lung cancer detected 3 Alive, cancer-free 5 yr
3 Deaths
1 Cancer
1 COPD
1 Heart
66 Studied, no cancer—CT scan
65/66 (98%)
5 yrs, no cancer
Spirometry 58/66 (88%)
Sputum cytology 52/66 (79%)
8 Dead, no lung cancer COPD 3, CHF 1,
multiorgan failure 1,
ALS 1, esophageal
cancer 1, metastatic
cancer 1
6 Not formally restudied, but
monitored through
medical record and/or
phone calls—no
symptoms or signs of
cancer
Alive 5 yr
2 Lost to follow-up Unknown
CHF, congestive heart failure; ALS, amyotrophic lateral sclerosis.
TABLE 3. Group B: Outcome of 38 High-Risk Patients Not
Screened for Lung Cancer
No. of
Patients
Status
Lung CA
Diagnosed
1 Squamous cell
CA, Stage I Alive 5 yr
2 (5.2%) 1 Non-small cell CA,
stage IV
Dead,6mo
18 Medical records
monitored, no
lung CA
8 Died, not lung CA
10 Lost to follow-up
38 Total patients
TABLE 4. Lung Cancer Subsequently Diagnosed in 10
Patients in Group C of 304 Patients Not Screened for
Carcinoma
Patient No. Cell Type Stage Survival Months
1 Adenocarcinoma I Alive, 40 mo
2 Adenocarcinoma IV Alive, 36 mo
3 Small cell Limited Alive, 72 mo
4 Small cell Advanced Dead, 8 mo
5 Adenocarcinoma IV Dead, 4 mo
6 Squamous cancer I Alive, 12 mo
7 Small cell Limited Alive, 20 mo
8 Non-small cell IIIA Dead
9 No biopsy, CT chest scan
consistent with large
primary lung CA with
metastases
IV Dead
10 No biopsy, CT scans,
chest and head showed
large hilar mass and
brain metastasis
IV Dead, 1 mo
TABLE 5. Summary Information for the 3 Groups of
Patients at High Risk for Lung Cancer
Total No.
Patients Sex M/F
Age, Range
(Mean) (yr)
Follow-Up
Information
Available
Group A 88 47/41 52–85 (68.4) 86/88 (98%)
Group B 38 23/15 52–87 (66.0) 28/38 (74%)
Group C 304 186/118 50–88 (64.3) 264/304 (87%)
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completed in 2 to 4 minutes and required1 minute to score.
The questionnaire seemed to be effective in identifying high-
risk patients for lung cancer, acknowledging that the power of
the questionnaire was the smoking history portion. Only one
patient was diagnosed with lung cancer with a low smoking
history, and his risk factor seeming to be occupational, as an
ex-uranium miner.
In ranking the efficacy of the screening studies, a chest
CT scan was the most powerful tool with five of the six (83%)
positive, whereas sputum cytology testing was positive in one
of the six (16%) patients. This individual, however, was
diagnosed solely on an abnormal sputum test, and several CT
scans failed to detect the lesion. Chest radiographs failed to
show the cancer in four of the six cases (66%) and were not
used in follow-up screening at 3 and 5 years.
Serial spirometry tests during the 5 years of the study
largely confirmed airflow obstruction with slight overall gen-
eral deterioration. However, several individuals who under-
went sequential screening studies showed normal follow-up
spirometry, indicating that their initial airflow obstruction
was not chronic obstructive pulmonary disease, but rather
reversible airway disease. With the advent of minimally
invasive lung-sparing, surgical procedures, such as video
assisted thoracoscopic surgery, and improved radiation ther-
apy modalities, even patients with severely reduced lung
function and the elderly can be offered the hope for lung
cancer cure.
We detected lung cancer in 6.8% (6/88) high-risk
individuals when monitored for 5 years. Other studies3,4,11
reported initial cancer detection rates of 1.2 to 1.6%, when
high-risk individuals are defined by less rigorous criteria and
airflow obstruction is not included. The annual lung cancer
rate was 0% in this study, when compared with 0.2% reported
by Henschke et al., likely a result of the small number of
subjects reported in this study. By restricting the selection
criteria as we have done, a higher percentage of cancer should
be identified, but at the risk of missing some cancers in
low-risk individuals. Relaxing the high-risk criteria will iden-
tify more cancers, but at a lower percentage of the group as
a whole, resulting in more expense and potential screening
risks. We chose to tighten our high-risk criteria and add
airflow obstruction to collect this “low-hanging fruit.”10
An unique aspect of this study was that it was per-
formed in a primary care medicine practice. We encountered
widespread community support by the participating physi-
cians, patients, hospital testing facility, and our local health
maintenance organization. Most of the participating physi-
cians strongly supported this project and often use the abnor-
mal spirometry, cytology, and radiologic results to educate
patients about smoking and smoking cessation. The inoffice
spirometry and radiograph testing did not seem to adversely
affect patient flow, especially later in the project when staff
was more familiar with the procedures. The cost for lung
cancer detection was not inordinately expensive, as described
previously, i.e., $12,000 per patient found in the highest
risk patients with airflow obstruction.5
The United States Preventative Services Task Force
and the American Cancer Society consider CT scanning for
early detection of lung cancer an unresolved issue and rec-
ommend that high-risk patients discuss with their physician
the risk and benefits of screening. Data show that CT scan
screening can detect cancer at early stage; however, improve-
ment in mortality rates has not been documented. The eagerly
awaited results of the National Lung Screening Trial spon-
sored by the National Cancer Institute evaluating 50,000
current and ex-smokers for lung cancer will hopefully pro-
vide more guidance for the clinician.
In conclusion, we identified individuals at high risk for
lung cancer using a simple self-administered questionnaire
and abnormal spirometry, and we detected lung cancer in six
of these 88 individuals. In total, 18 lungs cancers were
diagnosed in patients identified by our questionnaire as being
at high risk for lung cancer. We recommend that physicians
assess their patients for cancer risk with a questionnaire and
spirometry and that the physician discuss with the patient
cancer screening.
Although the total numbers are too small to draw final
conclusions, the thing that makes this study most unique is
that it was done in the primary care sector by primary care
physicians where patients came with general health issues.
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